Ignite Creation Date:
2025-12-26 @ 12:15 PM
Ignite Modification Date:
2026-01-01 @ 2:50 AM
Study NCT ID:
NCT00096200
Status:
COMPLETED
Last Update Posted:
2022-02-08
First Post:
2004-11-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-08
Start Date Type:
None
Primary Completion Date:
2011-04-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-08
Completion Date Type:
ACTUAL
First Submit Date:
2004-11-09
First Submit QC Date:
None
Study First Post Date:
2004-11-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-11-08
Results First Submit QC Date:
None
Results First Post Date:
2012-12-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-13
Last Update Post Date:
2022-02-08
Last Update Post Date Type:
ACTUAL